0
     

Report Added
Report already added
Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Report Scope:

The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.

Report Includes:

- 26 data tables and 28 additional tables
- An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
- Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
- Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region
- Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc.
- Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds
- Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
- Review of selected patents and patent applications on organoids, and emerging developments in the global market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading Organoids market players, including Cellesce Ltd., Corning Inc., Merck KGaA, Thermo Fisher Scientific Inc., Hubrecht Organoid Technology (HUB), and STEMCELL Technologies Inc.
Table of Contents

Chapter 1 Introduction
Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Information Sources and Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Animal Model Market Technology Background
Methods of Animal Model and 3D Cell Culture Modification
Physical and Chemical Mutations
Targeted Mutations
Other Technologies
Laboratory Animal Models
Market Definition
Animal Model Lines
Common Species of Laboratory Animals
Chapter 4 Impact of COVID-19 on the Global Market for Organoids
Overview
Impact of COVID-19 on Organoids
Conclusion
Chapter 5 Market Dynamics
Market Drivers
Increasing Emphasis on Developing Alternative Approaches to Animal Testing
Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth
Increasing Adoption of the Organoid Technology for Wide Range of Applications
Market Restraints
Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells
Concerns Associated with the Integration of Organoids into Current Workflows
Market Opportunities
Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine
Chapter 6 3D Cell Technology Background
3D Cell Cultures
Spheroids
2D Cultures vs. 2.5D Cultures vs. 3D Cultures
Scaffold-Based and Scaffold-Free 3D Cell Cultures
Scaffold-Free 3D Cell Cultures
Scaffold-Based 3D Cell Cultures
Tissue Engineering and Bioprinting
3D Bioprinting Technology
Types of Bioprinting Methods
Microfluidic Organ-on-Chip Platforms
Types of Organ-on-Chip Devices
Chapter 7 Market Breakdown by Organ Type
Global Market for Organoids, by Organ Type
Intestine
Market Size and Forecast
Liver
Market Size and Forecast
Stomach
Market Size and Forecast
Pancreas
Market Size and Forecast
Lung (Pulmonary)
Market Size and Forecast
Kidney
Market Size and Forecast
Others
Cardiac Organoids
Cancer Organoids
Market Size and Forecast
Chapter 8 Market Breakdown by Application
Global Market for Organoids, by Application
Developmental Biology
Market Size and Forecast
Drug Discovery and Personalized Medicine
Market Size and Forecast
Regenerative Medicine
Market Size and Forecast
Pathology of Infectious Disease
Market Size and Forecast
Drug Toxicity and Efficacy Testing
Market Size and Forecast
Chapter 9 Market Breakdown by Region
Global Market for Organoids, by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
Chapter 10 Patent Review/New Developments
Chapter 11 Analysis of Market Opportunities
Market Opportunities: Animal Models
Market Opportunities: 3D Cell Culture Segment
Organs-on-Chip
Organoids
Bioprinting
Advantages and Disadvantages of 3D Cell Cultures and Animal Models
Animal Models
3D Cell Cultures in General
Organoids
Organs-on-Chip
Chapter 12 Competitive Landscape
Chapter 13 Profiles of Companies and Important Institutions
Animal Model Companies
ALPHA GENESIS INC.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
ENVIGO
GENOWAY S.A.
LABCORP DRUG DEVELOPMENT (COVANCE INC.)
THE JACKSON LABORATORY
JANVIER LABS
OAK HILL GENETICS
PRIMGEN
TACONIC BIOSCIENCES
TRANSGENIC INC.
TRANSPOSAGEN BIOPHARMACEUTICALS INC.
Bioprinting and Regenerative Medicine Companies
ALLEVI
ASPECT BIOSYSTEMS LTD.
BIOINK SOLUTIONS INC.
CELLINK INC.
COLLPLANT HOLDINGS LTD.
EAST RIVER BIOSOLUTIONS/XYLYX BIO
EPIBONE
MATTEK CORP.
NANO 3D BIOSCIENCES INC.
ORGANOVO HOLDINGS INC.
PEPGEL LLC
REGENHU
TEVIDO BIODEVICES INC.
TISSUSE GMBH
Organ-on-Chip Companies
AXOSIM
EMULATE INC.
KIRKSTALL LTD.
MICRONIT MICROTECHNOLOGIES
MIMETAS
TARA BIOSYSTEMS INC.
Organoid Companies
3DNAMICS INC.
CELLESCE
CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER
CROWN BIOSCIENCE
CORNING INC.
DEFINIGEN
HUBRECHT ORGANOID TECHNOLOGY (HUB)
MERCK KGAA
R&D SYSTEMS INC.
STEMCELL TECHNOLOGIES INC.
THERMO FISHER SCIENTIFIC
TREVIGEN INC. (BIO-TECHNE)
Other 3D Cell Culture Companies
3D BIOTEK LLC
ADVANCED BIOMATRIX INC.
HORIZON DISCOVERY LTD.
INSPHERO INC.
PROMOCELL GMBH
REPROCELL INC.
SYNTHECON INC.

List of Tables
Summary Table : Global Market for Organoids, by Organ Type, Through 2027
Table A : Comparison of Changes in the Segmentation of the Old and New Version of the Report
Table 1 : Global Market for Organoids, by Organ Type, Through 2027
Table 2 : Global Market for Intestine Organoids, by Region, Through 2027
Table 3 : Global Market for Liver Organoids, by Region, Through 2027
Table 4 : Global Market for Stomach Organoids, by Region, Through 2027
Table 5 : Global Market for Pancreatic Organoids, by Region, Through 2027
Table 6 : Global Market for Lung Organoids, by Region, Through 2027
Table 7 : Global Market for Kidney Organoids, by Region, Through 2027
Table 8 : Global Market for Other Organoids Segment, by Region, Through 2027
Table 9 : Global Market for Organoids, by Application, Through 2027
Table 10 : Global Market for Organoids in Developmental Biology, by Region, Through 2027
Table 11 : Global Market for Organoids in Drug Discovery and Personalized Medicine, by Region, Through 2027
Table 12 : Global Market for Organoids in Regenerative Medicine, by Region, Through 2027
Table 13 : Global Market for Organoids in Pathology of Infectious Disease, by Region, Through 2027
Table 14 : Global Market for Organoids in Drug Toxicity and Efficacy Testing, by Region, Through 2027
Table 15 : Global Market for Organoids, by Region, Through 2027
Table 16 : North American Market for Organoids, by Organ Type, Through 2027
Table 17 : North American Market for Organoids, by Country, Through 2027
Table 18 : European Market for Organoids, by Organ Type, Through 2027
Table 19 : European Market for Organoids, by Country, Through 2027
Table 20 : Asia-Pacific Market for Organoids, by Organ Type, Through 2027
Table 21 : Asia-Pacific Market for Organoids, by Country, Through 2027
Table 22 : Rest of the World Market for Organoids, by Organ Type, Through 2027
Table 23 : Review of Selected Patents and Patent Applications on Organoids, 2008–2021
Table 24 : Global Number of Transplanted Organs, by Country, 2017
Table 25 : Global Organoids Vendors, by Ranking, 2021
Table 26 : Alpha Genesis Inc.: Recent Developments, 2017–2020
Table 27 : Charles River Laboratories International Inc.: Recent Developments, 2020–2022
Table 28 : Envigo: Types of Laboratory Animals
Table 29 : Envigo: Recent Developments, 2021–2022
Table 30 : GenOway: Recent Developments, 2018–2022
Table 31 : LabCorp Drug Development: Recent Developments, 2022
Table 32 : The Jackson Laboratory: Recent Developments, 2021
Table 33 : Janvier Labs: Segments
Table 34 : Taconic Biosciences: Segments
Table 35 : Transgenic Inc.: Segments
Table 36 : Transgenic Inc.: Company Financials, 2014–2018
Table 37 : Transposagen Biopharmaceuticals Inc.: Segments
Table 38 : Organovo: Expenses on R&D, 2016–2020
Table 39 : Cellesce.: Recent Developments, 2018–2022
Table 40 : Cincinnati Children's Hospital Medical Center: Recent Developments, 2021
Table 41 : Crown Bioscience: Recent Developments, 2021–2022
Table 42 : Corning Inc.: Recent Developments, 2018–2021
Table 43 : DefiniGEN: Recent Developments, 2020–2021
Table 44 : Hubrecht Organoid Technology (HUB): Recent Developments, 2017–2021
Table 45 : Merck KGaA: Products Offered
Table 46 : Merck KGaA: Recent Developments, 2020–2021
Table 47 : STEMCELL Technologies Inc.: Recent Developments, 2018–2022
Table 48 : Thermo Fisher Scientific: Products Offered
Table 49 : Thermo Fisher Scientific: Recent Developments
Table 50 : 3D Biotek LLC: Segments
Table 51 : In Sphero Inc.: Segments
Table 52 : Reprocell Inc.: Acquisitions

Report Title: Laboratory Animal Models, 3D Cultures and Organoids: Global Markets


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline